This inventor holds 1 USPTO granted patent. Top assignee: Cosmo Bio Co., Ltd.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Tomi Murakami: Innovator in Exosome Detection
Introduction
Tomi Murakami is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the detection of exosomes. His innovative work has led to the development of a unique monoclonal antibody that enhances the sensitivity and specificity of exosome detection.
Latest Patents
Tomi Murakami holds 1 patent for his invention titled "Monoclonal antibody for detecting exosomes." This patent describes a monoclonal antibody capable of detecting or capturing exosomes by recognizing specific amino acid sequences. The antibody can identify CD9, CD63, or CD81 on exosomes in a living body, showcasing excellent sensitivity and specificity.
Career Highlights
Murakami is currently associated with Cosmo Bio Co., Ltd., where he continues to advance his research in biotechnology. His work has been instrumental in improving methods for exosome detection, which has implications for various medical applications.
Collaborations
Tomi Murakami has collaborated with notable colleagues, including Hideki Ohta and Chihiro Okada, who contribute to his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Tomi Murakami's contributions to the field of exosome detection through his patented monoclonal antibody represent a significant advancement in biotechnology. His work continues to influence research and applications in this vital area.